2BB score and signals
MapLight Therapeutics, Inc.’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 3 | Very Low |
Company facts
| Headquarters | Redwood City, California, United States |
| Founded | 2018 |
| Employees | 133 |
| 52-week range | $12.25 – $37.02 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-12-01 | — | -1.2747 | — | $0.00 |
| 2026-09-01 | — | -1.3552 | — | $0.00 |
| 2026-05-14 | -1.34 | -1.1153 | $0.00 | $0.00 |
| 2026-03-02 | — | -1.0149 | — | $0.00 |
2BBBullish & Bearish